Melina Pectasides

978 total citations
26 papers, 756 citations indexed

About

Melina Pectasides is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Melina Pectasides has authored 26 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Melina Pectasides's work include Testicular diseases and treatments (6 papers), Neuroblastoma Research and Treatments (4 papers) and Lung Cancer Research Studies (4 papers). Melina Pectasides is often cited by papers focused on Testicular diseases and treatments (6 papers), Neuroblastoma Research and Treatments (4 papers) and Lung Cancer Research Studies (4 papers). Melina Pectasides collaborates with scholars based in Greece and United States. Melina Pectasides's co-authors include Dimitrios Pectasides, D. Pectasides, Maria Nikolaou, T. Economopoulos, Theofanis Economopoulos, Dimitrios Farmakis, Maria Koumpou, V. Kostopoulou, N. Mylonakis and S. Raptis and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Melina Pectasides

24 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melina Pectasides Greece 15 388 225 184 129 106 26 756
A. Athanassiou Greece 14 191 0.5× 194 0.9× 103 0.6× 110 0.9× 92 0.9× 33 479
Jean-Marie Cuillerot United States 12 1.4k 3.6× 152 0.7× 511 2.8× 154 1.2× 94 0.9× 31 1.6k
Tatjana Vlajnic Switzerland 17 415 1.1× 153 0.7× 223 1.2× 203 1.6× 27 0.3× 53 747
Takeshi Hisamatsu Japan 16 298 0.8× 52 0.2× 65 0.4× 287 2.2× 162 1.5× 31 820
Kathrin Glatz Switzerland 8 336 0.9× 128 0.6× 118 0.6× 97 0.8× 26 0.2× 12 581
Norifumi Hattori Japan 16 306 0.8× 238 1.1× 217 1.2× 275 2.1× 7 0.1× 91 889
R.A. Valdés-Olmos Netherlands 14 187 0.5× 142 0.6× 133 0.7× 34 0.3× 16 0.2× 25 524
Kazutoshi Murata Japan 15 259 0.7× 192 0.9× 264 1.4× 127 1.0× 50 0.5× 53 751
Taiichi Nakagawa Japan 11 157 0.4× 251 1.1× 250 1.4× 68 0.5× 38 0.4× 15 1.1k
Jong Sun Choi South Korea 14 178 0.5× 67 0.3× 108 0.6× 139 1.1× 15 0.1× 24 481

Countries citing papers authored by Melina Pectasides

Since Specialization
Citations

This map shows the geographic impact of Melina Pectasides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melina Pectasides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melina Pectasides more than expected).

Fields of papers citing papers by Melina Pectasides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melina Pectasides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melina Pectasides. The network helps show where Melina Pectasides may publish in the future.

Co-authorship network of co-authors of Melina Pectasides

This figure shows the co-authorship network connecting the top 25 collaborators of Melina Pectasides. A scholar is included among the top collaborators of Melina Pectasides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melina Pectasides. Melina Pectasides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Arighno, Glenn O. Allen, Soroush Rais‐Bahrami, et al.. (2025). Prostate zonal impact of 5α‐reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancer. British Journal of Urology. 137(2). 332–338.
2.
Kalva, Sanjeeva P., Melina Pectasides, Kalpana Yeddula, et al.. (2013). Factors Affecting Survival following Chemoembolization with Doxorubicin-eluting Microspheres for Inoperable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 24(2). 257–265. 10 indexed citations
3.
Ghazani, Arezou A., Melina Pectasides, Amita Sharma, et al.. (2013). Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance. Nanomedicine Nanotechnology Biology and Medicine. 10(3). 661–668. 32 indexed citations
4.
Kalva, Sanjeeva P., Melina Pectasides, Raymond Liu, et al.. (2013). Safety and Effectiveness of Chemoembolization with Drug-Eluting Beads for Advanced-Stage Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 37(2). 381–387. 63 indexed citations
5.
Ghazani, Arezou A., Shaunagh McDermott, Melina Pectasides, et al.. (2013). Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 1009–1017. 29 indexed citations
6.
Pectasides, Dimitrios, Petroula Arapantoni-Dadioti, Christos Valavanis, et al.. (2006). HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.. PubMed. 26(1B). 647–53. 58 indexed citations
7.
Pectasides, Dimitrios, Dimitrios Farmakis, & Melina Pectasides. (2006). The Management of Stage I Nonseminomatous Testicular Germ Cell Tumors. Oncology. 71(3-4). 151–158. 2 indexed citations
8.
Pectasides, Dimitrios, Melina Pectasides, Amanda Psyrri, et al.. (2006). Cisplatin-Based Chemotherapy for Merkel Cell Carcinoma of the Skin. Cancer Investigation. 24(8). 780–785. 32 indexed citations
9.
Pectasides, D., Amanda Psyrri, Melina Pectasides, & Theofanis Economopoulos. (2006). Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?. Expert Opinion on Pharmacotherapy. 7(8). 975–987. 12 indexed citations
10.
Pectasides, D., Melina Pectasides, & T. Economopoulos. (2006). Merkel cell cancer of the skin. Annals of Oncology. 17(10). 1489–1495. 81 indexed citations
11.
Pectasides, Dimitrios, Melina Pectasides, & T. Economopoulos. (2006). Systemic chemotherapy in locally advanced and/or metastatic bladder cancer. Cancer Treatment Reviews. 32(6). 456–470. 30 indexed citations
12.
Pectasides, Dimitrios, Maria Koumpou, Asimina Gaglia, et al.. (2006). Dermatomyositis associated with breast cancer.. PubMed. 26(3B). 2329–31. 15 indexed citations
13.
Pectasides, Dimitrios, Melina Pectasides, & Maria Nikolaou. (2005). Adjuvant and Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: Literature Review. European Urology. 48(1). 60–68. 53 indexed citations
14.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2005). Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial. Annals of Oncology. 16(2). 294–299. 71 indexed citations
15.
Farmakis, Dimitrios, Melina Pectasides, & Dimitrios Pectasides. (2005). Recent Advances in Conventional-Dose Salvage Chemotherapy in Patients with Cisplatin-Resistant or Refractory Testicular Germ Cell Tumors. European Urology. 48(3). 400–407. 13 indexed citations
16.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2004). Gemcitabine and oxaliplatin (GEMOX) in patients withcisplatin-refractory germ cell tumors: a phase II study. Annals of Oncology. 15(3). 493–497. 75 indexed citations
17.
Pectasides, Dimitrios, Melina Pectasides, Dimitrios Farmakis, et al.. (2004). Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: A phase II study. Gynecologic Oncology. 95(1). 165–172. 42 indexed citations
18.
Pectasides, D., Dimitrios Farmakis, Melina Pectasides, et al.. (2004). Docetaxel versus docetaxel plus irinotecan as second line chemotherapy in advanced non-small cell lung cancer (NSCLC): A randomized phase II trial. Journal of Clinical Oncology. 22(14_suppl). 7033–7033. 2 indexed citations
19.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2003). Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Annals of Oncology. 14(4). 537–542. 26 indexed citations
20.
Pectasides, Dimitrios, Melina Pectasides, Dimitrios Farmakis, et al.. (2003). Testicular Function in Patients with Testicular Cancer Treated with Bleomycin-Etoposide-Carboplatin (BEC90) Combination Chemotherapy. European Urology. 45(2). 187–193. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Athanassiou Breakdown of academic impact, for papers by Jean-Marie Cuillerot Breakdown of academic impact, for papers by Tatjana Vlajnic Breakdown of academic impact, for papers by Takeshi Hisamatsu Breakdown of academic impact, for papers by Kathrin Glatz Breakdown of academic impact, for papers by Norifumi Hattori Breakdown of academic impact, for papers by R.A. Valdés-Olmos Breakdown of academic impact, for papers by Kazutoshi Murata Breakdown of academic impact, for papers by Taiichi Nakagawa Breakdown of academic impact, for papers by Jong Sun Choi
Rankless by CCL
2026